| 产品描述: | EGF和PDGF受体酪氨酸激酶的抑制剂;an inhibitor of the EGF and PDGF receptor tyrosine kinases;RG-13022是酪氨酸激酶酪氨酸磷酸化抑制剂。报告表明,在癌细胞研究中,RG-13022抑制表皮生长因子(EGF)刺激的癌细胞增殖。此外,已描述了RG-13022可以抑制EGF,血小板衍生的生长(PDGF)信号传导和PDGF增强的DNA合成。RG-13022是EGFR和PDGFR的抑制剂。;RG-13022 is a Tyrosine kinase tyrphostin. Reports indicate that RG-13022 suppresses epidermal growth factor (EGF)-stimulated cancer cell proliferation in cancer cell studies. Additionally, RG-13022 has been described to inhibit EGF, platelet-dervied growth (PDGF) signaling, and PDGF enhanced DNA synthesis. RG-13022 is an inhibitor of EGFR and PDGFR. |
| 靶点: |
IC50: 4 μM (EGF receptor autophosphorylation) |
| 体内研究: |
RG13022 在裸鼠体内抑制肿瘤生长。RG13022 还可以延长这些荷瘤裸鼠的寿命。 |
| 参考文献: |
1. Yoneda T, et al. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice. Cancer Res. 1991 Aug 15;51(16):4430-5. 2. Reddy KB, et al. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor. Cancer Res. 1992 Jul 1;52(13):3636-41. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.755 ml |
18.776 ml |
37.552 ml |
| 5 mM |
0.751 ml |
3.755 ml |
7.51 ml |
| 10 mM |
0.376 ml |
1.878 ml |
3.755 ml |
| 50 mM |
0.075 ml |
0.376 ml |
0.751 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |